Investor Alert- TRTC Revenue & Stock- Price !! (

New Post Public Reply Private Reply Replies (0) Message Board
cb11
Investor Alert- TRTC Revenue & Stock- Price !!

( Completed Version )



This as attempt for by mutual consent and systematical manner

All Here once to be Agree on same Revenues or Stock- Price

Estimate numbers, because everybody just coming- up with

something different is only causing confusions and really

nothing for the GOOD we need to Relay On !





1. Up-Front lets be Agree on the Stock EPS- Ratios & Earning Definition :

- Blue- Chips have an EPS- Ratio of 10 - 20x , OK ?!

- None Blue- Chips have an EPS- Ratio of 30 - 60x , OK ?!

- TRTC as No Blue- Chip to apply middle EPS- Ration of 45x ?!

- TRTC Stocks instead as Issued & Outstanding 88 Mn take 100 Mn ?!

( OTC Markets Registered Free- Floating Stocks of 48 Mn, same as 2012 )

- Revenue is Not Earning and Earning is the Margin Not Net- Income

and Net- Income Is after Deductions of Any Expenses from Earning

and before of Any Taxes ?!





2. For Annual Revenues & Earning to calculate we have TRTC Information’s as :



- 5-Acre Production Plant Revenue $ 10 Mn - we apply 9 Mn by Margin 40 % !



- Contracts with NB Plants of 100% & GroRite of 50% From Its Productions !

NB & GroRite Contracts grant TRTC a Royalty of 10% from its Revenues,

the complain send TRTC to increase this to at least 20% since any Agency

Royalty Standards are between 30 - 60% depending on Items- Price Range.

Wondering when the Vande Vredes will be more reasonable to allow the

Royalty of 20%, but resulting we now need to calculate by 10% only.

From NB Plants is known Revenues $ 6 Mn and GroRite $ 4 Mn, by the

Contracts % Resulting to $ 8 Mn, but we take $ 7 Mn to calculate !



- We have now the Starting Q2 of 65 Days Edible Garden Corp. participation

resulting to $ 0,599 Mn, taking this for the Quarters of usually 90 Days

would result to $ 0,829 Mn, but until now we have no TRTC reply of why

Its Estimate Q2 for 65 Days of $ 0,8 Mn was not achieved and therefore

it becomes difficult to use the numbers for calculations !


- Florida Project of Revenue $ 800,000 , where TRTC get a Royalty of 15%,

the complain for after the first Business- Year to increase this also to 20%

is made to TRTC, but since there is not yet any TRTC reconfirmation we

need to calculate this by the Royalty of 15% !



- For the Hydroponic Equipments & Accessories & Companies Sales

we have not any reliable Estimate Numbers and need to wait until

the next Version of Investors Presentation.

Therefore at the moment we cannot consider this !



- For TRTC’s Electricity Management Matter we have also No Numbers

until now and therefore cannot consider this !



This Above Points 1. and 2. As Calculation Basis !!





According to Above and to make it a little more simple,

the Calculation Estimates of Revenue, Earnings and

Stock- Price only as from 2014 :



- New 5-Acre Production Plant, Revenue $ 9 Mn, Earning $ 3,6 Mn !



- NB Plants & GroRite Contracts, Revenue $ 7 Mn, Earning $ 0,7 Mn !



- Florida Project, Revenue $ 0,8 Mn, Earning $ 0,12 Mn !

( Without New Such Projects Announced US Wide ! )



- Hydroponic Equipments & Accessories & Companies Sales not considered !



- The TRTC’s Electricity Management Matter not considered !



( Without Any MJ Growing Projects May Soon Possible ! )



As Resulting :

2014 Revenue Estimate = $ 16,8 Mn

2014 Earning Estimate = $ 4,42 Mn



TRTC Stock- Price = $ 1,99 at for example 100 Mn Stocks by EPS- Ratio 45x !!

This within the first 6 Months of 2014, depending on TRTC Progress

Information’s and the resulting Investors Reactions !!



At during 2012 until Q1 2013, the Monthly Money Net- Loss

was at $ 0,5 Mn and this now by 50% Less has improved !.

At Same Rate TRTC Will Be Writing Black- Profit Numbers

Already As From Within November 2013 !!


If TRTC by the US Fed. would be allowed to grow MJ, it compare

the Bio·Vegetable & Herbs could provide a 7 - 10x Higher Profit-

Margin resulting the Stock- Price of $ 1,99 to increase 6 - 8x !!





To be conservative on the reliable save side, all considered Aspects

are by reductions applied or if at the moment not any reliable

numbers exist not even been considered !



Any other Facts or Experiences are Welcoming only !





Happy TRTC Investing





TRTC Q2 Success Right On Track !!

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Neera Tanden's Progressive Vision for 2027 and Beyond

Updated Category News Views 64

Neera Tanden Sets the Stage for 2027 When it comes to politics, everyone’s got their two cents, but Neera Tanden’s unpacking a whole piggy bank of progressive dreams. Set against the backdrop of a freshly reshuffled Congress post-midterms, she’s poised to dish out her roadmap for the future at the National Press Club on November 9. A Gathering of Minds This ain't...

Continue Reading
Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 214

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
KFC Teams with Marvel for Record-Breaking Menu Launch

Updated Category News Views 108

Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 93

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
Global Mayors Convene in Ningbo for Urban Development

Updated Category News Views 63

Navigating Global Urban Challenges Amidst the backdrop of economic prowess and cultural diversity, the 2026 Global Mayors Dialogue in Ningbo has swiftly become a hotbed for city leaders hunting solutions. This wasn't your run-of-the-mill conference—mayors flocked from across the globe, all converging in this vibrant pocket of eastern China to unveil their visions for...

Continue Reading
Duolingo Faces Class Action: Investors React Strongly

Updated Category News Views 63

Duolingo's Rough Road: A Lawsuit in Motion Alright, fasten your seatbelts, because we've got a real rollercoaster here with Duolingo (NASDAQ: DUOL). You know, the language-learning app that's been pushing ads like it's going out of style? Well, investors are seeing red—not the kind you want, either. This class action lawsuit looming over them is like an unwelcome...

Continue Reading
Saudi Tourism Steals the Spotlight at WTM London 2026

Updated Category News Views 86

A Glimpse into Saudi's Ambitious Tourism Drive Ever feel like someone just decided to dominate the conversation at a global pow-wow? Well, that's the vibe Saudi Arabia brought to the World Travel Market (WTM) in London for 2026. With His Excellency Ahmed Al-Khateeb making headlines together with a mighty entourage of 37 tourism partners, the message was clear: Saudi...

Continue Reading
New CMO Joins ARTHEx: Boosting Innovative RNA Focus

Updated Category News Views 26

ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...

Continue Reading
HashKey and AMBR Unite to Push AI Frontiers in Finance

Updated Category News Views 53

Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...

Continue Reading
Acuity Analytics Charts Ambitious AI-Driven Future

Updated Category News Views 128

The New Era at Acuity Analytics Has Begun Isn't it something when a company decides to shake things up in such a daring way? Acuity Analytics just gave the financial sector a reason to sit up and pay attention. They've brought in Jon O'Donnell as the new Chief Executive Officer, a move that's got the city talking. O'Donnell is no rookie; he's a former IBM heavyweight and...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rapid Growth of the Contract Intelligence Market

Updated Category News Views 194

Understanding the Contract Intelligence Market The contract intelligence market has become an essential component for organizations seeking to streamline their legal processes and optimize operational efficiency. Currently valued at over US$ 1,113.59 million, experts forecast that this market will grow substantially, surpassing US$ 7,212.65 million by 2033. This expected...

Continue Reading
Emerging Steel Giants: Vallourec and Posco Rise to Prominence

Updated Category News Views 130

Understanding the Growth Surge in Steel Stocks Recently, two prominent steel companies have garnered attention due to impressive growth metrics that show significant improvement. These advancements have reinforced their positions in the competitive steel market, indicating potential for further expansion. Vallourec SA: A Resilient Contender in Steel Production Vallourec...

Continue Reading
Illinois House Democrats Surge with Historic Gaines

Updated Category News Views 26

Turning the Election Tide in Illinois Damn, if you're not paying attention to what's shaking in Illinois, it's time to listen up. The Democrats under Speaker Emanuel "Chris" Welch are strutting their stuff, leaving an indelible mark on the political landscape. An eye-popping $35 million in campaign dough was raised, safeguarding every Democratic incumbent and managing to...

Continue Reading
Morgan Stanley's Caution on Roku Stock Signals Challenges Ahead

Updated Category News Views 148

Market Analysis of Roku's Stock Performance Concerns regarding Roku (NASDAQ: ROKU) have emerged as Morgan Stanley has lowered its price target for the stock to $60 from the previous $65. This decision comes despite the company experiencing a significant 35% surge in share prices following its Q2 2024 earnings report. The increase was fueled by expectations that the...

Continue Reading
Iterum Therapeutics Showcases Innovations at Investment Conference

Updated Category News Views 164

Iterum Therapeutics Set to Shine at Global Investment Conference Iterum Therapeutics plc (Nasdaq: ITRM), headquartered in Dublin, Ireland, and Chicago, is a leading clinical-stage pharmaceutical company dedicated to developing next-generation oral antibiotics. These groundbreaking treatments are designed to combat infections caused by multi-drug resistant pathogens in...

Continue Reading